soul trial oral semaglutide cardiovascular outcomes 2024 nejm results Cardiovascular Outcomes, Safety, and Tolerability With Oral Semaglutide: Insights for Managed Care A⬇️rate of eGFR decline in
Description
This comparison examines the clinical evidence, pharmacological differences, and the tradeoffs between semaglutide's proven track record and zovaglutide's convenience-focused development
Care plans may be adjusted over time based on provider review
To me, this suggests lower doses are placebo-like
Hartley P, Shentu Y, Betz-Schiff P, Golm GT, Sisk CM, Engel SS, Shankar RR
p = 0.01) (Table 2)
